Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy

OBJECTIVE: Erythropoietin (Epo) is neuroprotective in animal models of neonatal hypoxic-ischemic encephalopathy. We previously reported a phase I safety and pharmacokinetic study of Epo in neonates. This paper presents the neurodevelopmental follow-up of infants who were enrolled in the phase I clin...

Full description

Saved in:
Bibliographic Details
Published in:Pediatr Neurol
Main Authors: Rogers, Elizabeth E., Bonifacio, Sonia L., Glass, Hannah C., Juul, Sandra E., Chang, Taeun, Mayock, Dennis E., Durand, David J., Song, Dongli, Barkovich, Anthony J., Ballard, Roberta A., Wu, Yvonne W.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402201/
https://ncbi.nlm.nih.gov/pubmed/25439577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pediatrneurol.2014.08.010
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items